CymitQuimica logo

CAS 959841-49-7

:

Sortieren nach

Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 Produkte gefunden.
  • (E)-Akt inhibitor-IV

    CAS:
    (E)-Akt inhibitor-IV ((E)-AKTIV)  ((E)-AKTIV) is an inhibitor of PI3K-Akt.
    Formel:C31H29IN4S
    Reinheit:99.74% - 99.9%
    Farbe und Form:Solid
    Molekulargewicht:616.56

    Ref: TM-T9393

    1mg
    52,00€
    5mg
    110,00€
    1mL*10mM (DMSO)
    148,00€
    10mg
    170,00€
    25mg
    319,00€
    50mg
    444,00€
    100mg
    620,00€
    200mg
    875,00€
  • (E)-Akt inhibitor-IV

    CAS:
    (E)-6-(Benzo[d]thiazol-2-yl)-1-ethyl-2-(2-(methyl(phenyl)amino)vinyl)-3-phenyl-1H-benzo[d]imidazol-3-ium iodide
    Formel:C31H27IN4S
    Reinheit:98%
    Molekulargewicht:614.54

    Ref: IN-DG01433126

    10mg
    120,00€
    25mg
    219,00€
    50mg
    353,00€
    100mg
    583,00€
    250mg
    990,00€
  • (E)-Akt inhibitor-IV

    CAS:
    (E)-Akt inhibitor-IV is a potent and selective inhibitor of the protein kinase Akt. It has been shown to induce apoptosis in human tumor and Chinese hamster ovary cells. This analog of the Akt inhibitor is known for its anticancer properties, as it effectively inhibits the activity of kinases that promote cancer cell growth. The (E)-Akt inhibitor-IV has been found to be effective in treating various types of cancer, including breast and prostate cancer. Additionally, this inhibitor has been shown to enhance the anticancer effects of vitamin D in vitro. Overall, (E)-Akt inhibitor-IV is a promising therapeutic agent for cancer treatment due to its potent inhibitory effects on Akt activity and induction of apoptosis in cancer cells.
    Formel:C31H29IN4S
    Reinheit:Min. 95%
    Molekulargewicht:616.6 g/mol

    Ref: 3D-JNB84149

    25mg
    804,00€
    50mg
    1.214,00€
    100mg
    1.687,00€